热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-human CD14 Antibody
产品名称：
FITC anti-human CD14 Antibody
产品类别：
抗体
产品编号：
301803
产品应用：
301803
[价格]
规格 价格 库存
25tests ￥ 588 1

产品详情

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
African Green, Capuchin Monkey, Cow, Chimpanzee, Common Marmoset, Cotton-topped Tamarin, Dog, Pigtailed Macaque, Squirrel Monkey
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Full-length human CD14 protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The M5E2 antibody inhibits monocyte activation and cytokine production induced by LPS. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections, blocking of LPS stimulation4, and immunofluorescence microscopy5. Clone M5E2 is not recommended for immunohistochemical staining of formalin-fixed paraffin-embedded sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 301861 and 301862).

Application References

(PubMed link indicates BioLegend citation)
  1. McMichael A, et al. 1987. Leucocyte Typing III. Oxford University Press. New York.
  2. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York. (IHC-F)
  3. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  4. Power CP, et al. 2004. J. Immunol. 173:5229. (Block)
  5. Williams KC, et al. 2001. J. Exp. Med. 193:905.
  6. Iwamoto S, et al. 2007. J. Immunol. 179:1449. (FC) PubMed
  7. Santer DM, et al. 2010. J. Immunol. 485:4739. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Zizzo G, et al. 2012. J. Immunol. 189:3508. PubMed
  10. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  11. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Zhao M, et al. 2021. Frontiers in Cell and Developmental Biology. 9:652972. PubMed
  2. Wang H, et al. 2020. Cell Stem Cell. 28(3):535-549.e8. PubMed
  3. Chen X, et al. 2022. Front Bioeng Biotechnol. 10:915181. PubMed
  4. Chiu YL, et al. 2018. Immun Ageing. 15:27. PubMed
  5. Shoda H, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1308-y. PubMed
  6. Zhao Y, et al. 2021. Front Immunol. 12:665442. PubMed
  7. Bencze D, et al. 2022. Int J Mol Sci. 23:. PubMed
  8. Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
  9. Poran A, et al. 2020. Cell Reports Medicine. 1(8):100141. PubMed
  10. Wiernik A, et al. 2013. Clin Cancer Res. 19:3844. PubMed
  11. Schulthess J et al. 2019. Immunity. 50(2):432-445 . PubMed
  12. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  13. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  14. Ma X, et al. 2022. Front Oncol. 12:855570. PubMed
  15. Hecker A, et al. 2015. J Immunol. 195: 2325-2334. PubMed
  16. Sutton HJ, et al. 2021. Cell Reports. 34(6):108684. PubMed
  17. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  18. Woolsey C, et al. 2020. Scientific Reports. 10(1):3071.. PubMed
  19. Meng Y,et al. 2017. Cell Death Dis. . 10.1038/cddis.2017.505. PubMed
  20. Zhang D, et al. 2020. Oncoimmunology. 9:1744921. PubMed
  21. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  22. Jankeel A, et al. 2020. J Virol. :94. PubMed
  23. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  24. Li F, et al. 2022. Front Pharmacol. 13:1001552. PubMed
  25. Grivas A, et al. 2022. Front Immunol. 13:964274. PubMed
  26. Qi F, et al. 2022. Oncol Lett. 24:273. PubMed
  27. Saha R, et al. 2021. Sci Rep. 11:18849. PubMed
  28. Wang D, et al. 2020. J Cell Mol Med. 24:4212. PubMed
  29. Crifò B, et al. 2019. J Immunol. 202:1521. PubMed
  30. Yao J, et al. 2022. Front Pharmacol. 13:876076. PubMed
  31. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  32. Zhang S, et al. 2021. Stem Cells Int. 6616240:2021. PubMed
  33. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  34. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  35. Pucino V, et al. 2020. Cell Metabolism. 30(6):1055-1074.e8.. PubMed
  36. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  37. Autenrieth S, et al. 2015. Clin Transl Immunology. 4:50. PubMed
  38. Jackson R, et al. 2020. Viruses. 12:00. PubMed
  39. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  40. Donini M, et al. 2011. Prostate. 72:566. PubMed
  41. Rao Z, et al. 2019. J Immunol. 203:1031. PubMed
  42. Kletting S, et al. 2017. ALTEX. 35:211. PubMed
  43. Yang X, et al. 2019. Mol Med Rep. 19:1083. PubMed
  44. Liao HQ, et al. 2021. Am J Reprod Immunol. 86:e13406. PubMed
  45. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  46. Lin F, et al. 2020. Int J Oncol. 56:151. PubMed
  47. Wu Q, et al. 2022. Cancer Immunol Res. 10:182. PubMed
  48. Wang Z, et al. 2020. J Cell Mol Med. . PubMed
  49. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  50. Reyes M, et al. 2021. Sci Transl Med. 13:. PubMed
  51. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  52. Fekete T, et al. 2020. Front Immunol. 11:572960. PubMed
  53. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  54. Wells DK, et al. 2020. Cell. 183:818. PubMed
  55. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  56. Zavareh RB, et al. 2020. Cell Chemical Biology. 28(2):158-168.e5. PubMed
  57. Pierini S, et al. 2020. JCI Insight. 5:00. PubMed
  58. Wang SQ, et al. 2021. J Viral Hepat. 28:795. PubMed
  59. Langnau C, et al. 2021. Arterioscler Thromb Vasc Biol. 41:2080. PubMed
  60. Qu M, et al. 2021. Frontiers in Oncology. 11:659720. PubMed
  61. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  62. Hiatt J, et al. 2021. Cell Reports. 35(6):109105. PubMed
  63. Meng Q, et al. 2022. Oncol Lett. 23:83. PubMed
  64. Ceglia V, et al. 2022. Front Immunol. 12:786144. PubMed
  65. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
RRID
AB_314185 (BioLegend Cat. No. 301803) AB_314186 (BioLegend Cat. No. 301804)

Antigen Details

Structure
GPI-linked membrane glycoprotein, 53-55 kD
Distribution

Monocytes, macrophages, granulocytes (low)

Function
LPS receptor, clearance of Gram-negative pathogens
Ligand/Receptor
LPS
Cell Type
Granulocytes, Macrophages, Monocytes, Neutrophils
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
CD Molecules
Antigen References

1. Stocks S, et al. 1990. Biochem. J. 268:275.
2. Wright S, et al. 1990. Science 249:1434.

Gene ID
929 View all products for this Gene ID
UniProt
View information about CD14 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线